Press Releases - 2023-07-28

Date	Title	Company
28-Jul-2023	Glycopeptide antibiotics Market Revenue to Hit the US$6.6 Billion by 2030	The Wire Times
28-Jul-2023	Clinical Communication Software Market Primed for a Remarkable Expansion of 3.58 Billion by 2029	The Wire Times
28-Jul-2023	Computer Assisted Coding Market Poised for Remarkable Growth, projected to Hit US$ 13.08 Billion by 2030	The Wire Times
28-Jul-2023	Acute Spinal Cord Injury Market is Expected to Reach the Valuation of USD 9,892.5 Million by 2030	The Wire Times
28-Jul-2023	Fractional Laser Market to Reach $3.0 Billion by the End of 2030	The Wire Times
28-Jul-2023	Healthcare Information Technology (IT) Market Size Poised to Hit USD 1319.28 Billion and Grow at a CAGR of 16.8% by 2030	The Wire Times
28-Jul-2023	Myxoma Market to Witness Impressive Growth Potential of 6.50% by 2029	The Wire Times
28-Jul-2023	Disposable Incontinence Products Market Size Worth USD 15.89 Billion by 2030	The Wire Times
28-Jul-2023	Pediatric Home Healthcare Market Geared for Substantial Growth Rate of 7.8% by 2029	The Wire Times
28-Jul-2023	Electroporation Instruments Market is Projected a Momentous Growth of USD 1,447.80 Million by 2029	The Wire Times
28-Jul-2023	IO Biotech Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial at University of California Davis Comprehensive Cancer Center	IO Biotech
28-Jul-2023	OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain (“NCP”) Following Announcement of Clinical Trial Agreement with Tufts Medical Center	OKYO Pharma
28-Jul-2023	GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION’S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030	GILEAD
28-Jul-2023	Approval of the combination of Envirotainer and va-Q-tec´s pharma offering - to establish a complete portfolio of unrivalled temperature-controlled solutions	Envirotainer
28-Jul-2023	What nap times reveal about your child’s brain development	University of East Anglia
28-Jul-2023	Vitruvia Medical AG: Shareholders approved all proposals at the Annual General Meeting of Shareholders	Vitruvia Medical AG
28-Jul-2023	Evolva Holding SA: Evolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year	Evolva Holding SA
28-Jul-2023	Medacta Group SA: 2023 Half-Year Unaudited Top-Line Figures	Medacta Group SA
28-Jul-2023	Creative Enzymes Launches Innovative Instant Granules for Enhanced Bioprocessing Efficiency	Creative Enzymes
28-Jul-2023	Creative Enzymes Unveils Native Bacillus licheniformis Protease, Expanding Enzymatic Solutions for Various Industries	Creative Enzymes